Pancreatitis Trial, Recruiting NCT07168863 Sponsor: University of Tehran Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07168863
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older (either staying in hospital or attending as an outpatient) who are having a specific type of biopsy procedure called EUS-guided FNB (a biopsy taken using an ultrasound scope passed into the digestive tract)
  • People having this biopsy taken from a solid or fluid-filled growth located in the pancreas, the ampulla of Vater (a small opening where the bile duct meets the digestive tract), or a specific section of the bile duct that runs through the pancreas

Who may not be able to join:

  • People who are having a separate bile duct procedure called ERCP on the same day as the biopsy
  • People who are currently experiencing an active episode of acute pancreatitis (sudden, severe inflammation of the pancreas) at the time of the biopsy
  • People having a different type of biopsy called EUS-guided FNA (a finer needle sampling procedure, rather than a core tissue biopsy)
  • People with blood clotting levels that cannot be corrected to a safe level before the procedure (confirm with trial site)
  • People with a low platelet count that cannot be corrected to a safe level before the procedure (confirm with trial site)
  • People who do not wish to participate or are not willing to sign the consent form
  • People having a biopsy from a part of the bile duct where the biopsy needle does not pass through the pancreas

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +982182415104

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Tehran
Registry
ClinicalTrials.gov
Start date
11 September 2025
Est. completion
12 February 2027

Where this trial is recruiting

Iran

Primary endpoints

Incidence of Post-EUS-FNB acute pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov